本页面由Tiger Trade Technology Pte. Ltd.提供服务

Avalo Therapeutics Inc

16.46
-1.3000-7.32%
成交量:85.63万
成交额:1,506.65万
市值:3.75亿
市盈率:-2.82
高:18.47
开:18.00
低:16.38
收:17.76
52周最高:20.72
52周最低:3.39
股本:2,278.85万
流通股本:1,534.02万
量比:1.53
换手率:5.58%
股息:- -
股息率:- -
每股收益(TTM):-5.8400
每股收益(LYR):-5.8400
净资产收益率:-72.43%
总资产收益率:-34.12%
市净率:4.52
市盈率(LYR):-2.82

数据加载中...

2024/06/24

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/06/24

重要事件披露

Form 8-K - Current report
2024/06/24

重要事件披露

Form 8-K - Current report
2024/06/03

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/05/23

重要事件披露

Form 8-K - Current report
2024/05/13

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/05/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/13

重要事件披露

Form 8-K - Current report
2024/04/23

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/04/05

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/28

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

重要事件披露

Form 8-K - Current report
2023/12/29

重要事件披露

Form 8-K - Current report
2023/12/20

重要事件披露

Form 8-K - Current report